Given these results and the relevance of better understanding the mechanism of action of Riparin A, this study aimed to evaluate the effects of Riparin A on BNDF, VEGF and GluN2B genes expression and cytokine modulation in different brain areas in animals subjected to the chronic unpredictable mild stress (CUMS) model of depression. Here, VEGFA is linked to depressive symptom measurement.